Hydroxychloroquine lowers COVID-19 death rate, Henry Ford Health study finds


"A Henry Ford Health System study shows the controversial anti-malaria drug hydroxychloroquine helps lower the death rate of COVID-19 patients, the Detroit-based health system said Thursday. Officials with the Michigan health system said the study found the drug “significantly” decreased the death rate of patients involved in the analysis."

Be the first to comment

Please check your e-mail for a link to activate your account.